Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies
Titel:
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies
Auteur:
Mahadevan, D. Chiorean, E.G. Harris, W.B. Von Hoff, D.D. Stejskal-Barnett, A. Qi, W. Anthony, S.P. Younger, A.E. Rensvold, D.M. Cordova, F. Shelton, C.F. Becker, M.D. Garlich, J.R. Durden, D.L. Ramanathan, R.K.